Re: Saskia from Germany - new here
Posted: Fri Nov 08, 2019 1:14 pm
Tanja,
thank you for reaching out.
After the last conversation we had with Saskia here, I felt that she might be offended by the negative comments re. complimentary treatments she is having. For us it is not the new subject and not the first time we have to say that again - nothing should be assumed as beneficial for ASPS treatment if not proven. Anything that is done can affect in 3 ways - do better, do worse and do nothing, and if you do not have a proof if works in any particular way, there is a risk. Most of the alternative medicine treatments have no proof of action, and the science there is only limited to the dish experiments.
I am very concern that the alkaline infusions are given with the immunotherapy trial going on. Do you know what the alkaline infusions consist of - what is given/dosage and how they affect the mineralocortical hormones (aldosterone, cotrisol) and sodium-potassium balance, plus the red-white cells counts - lymphocytes, neuthrophils? I suspect it should affect that a lot since it is blends into the blood. Keytruda is her best chance for now and I would not risk loosing it for some non-proven benefits. Immunotherapy is a very gentle treatment and basically the person just have to be in its best help and I do not think the IV infusions are such an innocent thing during the immunotherapy clinical trial - the doctor leading the trial has to be notified about that for sure, as it can change the response to both drugs and their toxicity profile. I have seen that alkaline IV are used in emergency rooms for the hyperkalemia situations so for sure it can and will modify the bloodwork.
Saskia is a young person and her immune system should be good if just supported with the good food, sleep and exercise. IV is to rough of an intervention in my opinion, the alkaline cocktail she is having is good enough. Besides some people use the alkaline IV for the weight loss which you do not want.
About the FGFR4 mutation. There are some studies re. different genes mutations in ASPS, I will find that later. There are studies of the genetic alterations in ASPS but the up regulated growth factors are different between the patients and using the own patient tumor to analyze and find the better suited therapy is an interesting option but not always works. Besides there is usually a resistance develops to any growth factors inhibition when the body finds another pathway to go around this point, developing accessory pathways. There is usually a good response rate in TKI but even with the very active ones it is not uniform. As I understand, you are asking if it makes a sense to use the result of gene expression profiling that you got for the FGFR4 positivity. It is hard to say when the FGFR4 inhibitors are in the clinical trials - if any of them will work as intended, you should look at the Pubmed.gov for the articles
there was a pretty recent article about the gene expression profiling in ASPS, I have the PDF, but in general they say:
Different approaches including gene expression profiling, western blotting and immune profiling have revealed robust expression of angiogenic associated molecules including vascular endothelial growth factor receptor (VEGFR)1, VEGFR2, VEGFR3, epidermal growth factor (EGF), MET, RET, platelet derived growth factor (PDGF)B, PDGFRB and innate immunity related receptors such as toll-like receptors (TLR)2 and TLR9 in ASPS
https://www.sciencedirect.com/science/a ... 2218314306
they do not mention FGFR4 but we have seen that there might be difference between the patients especially based on the age as innate factors change as we age.
So in general, we do not know if it makes sense to seek the enrollment into the FGFR4 clinical trial. Right now she is on the best clinical trial as it shows by far the best results in ASPS by now, just try not to interfere with it. It is good that the antibiotics were avoided. What are the blood work results - any deviations from norm, any problems, what is the neutrophil/lymphocyte ratio (NLR)? I keep the table with the results Ivan get to watch for the changes and problems.
thank you for reaching out.
After the last conversation we had with Saskia here, I felt that she might be offended by the negative comments re. complimentary treatments she is having. For us it is not the new subject and not the first time we have to say that again - nothing should be assumed as beneficial for ASPS treatment if not proven. Anything that is done can affect in 3 ways - do better, do worse and do nothing, and if you do not have a proof if works in any particular way, there is a risk. Most of the alternative medicine treatments have no proof of action, and the science there is only limited to the dish experiments.
I am very concern that the alkaline infusions are given with the immunotherapy trial going on. Do you know what the alkaline infusions consist of - what is given/dosage and how they affect the mineralocortical hormones (aldosterone, cotrisol) and sodium-potassium balance, plus the red-white cells counts - lymphocytes, neuthrophils? I suspect it should affect that a lot since it is blends into the blood. Keytruda is her best chance for now and I would not risk loosing it for some non-proven benefits. Immunotherapy is a very gentle treatment and basically the person just have to be in its best help and I do not think the IV infusions are such an innocent thing during the immunotherapy clinical trial - the doctor leading the trial has to be notified about that for sure, as it can change the response to both drugs and their toxicity profile. I have seen that alkaline IV are used in emergency rooms for the hyperkalemia situations so for sure it can and will modify the bloodwork.
Saskia is a young person and her immune system should be good if just supported with the good food, sleep and exercise. IV is to rough of an intervention in my opinion, the alkaline cocktail she is having is good enough. Besides some people use the alkaline IV for the weight loss which you do not want.
About the FGFR4 mutation. There are some studies re. different genes mutations in ASPS, I will find that later. There are studies of the genetic alterations in ASPS but the up regulated growth factors are different between the patients and using the own patient tumor to analyze and find the better suited therapy is an interesting option but not always works. Besides there is usually a resistance develops to any growth factors inhibition when the body finds another pathway to go around this point, developing accessory pathways. There is usually a good response rate in TKI but even with the very active ones it is not uniform. As I understand, you are asking if it makes a sense to use the result of gene expression profiling that you got for the FGFR4 positivity. It is hard to say when the FGFR4 inhibitors are in the clinical trials - if any of them will work as intended, you should look at the Pubmed.gov for the articles
there was a pretty recent article about the gene expression profiling in ASPS, I have the PDF, but in general they say:
Different approaches including gene expression profiling, western blotting and immune profiling have revealed robust expression of angiogenic associated molecules including vascular endothelial growth factor receptor (VEGFR)1, VEGFR2, VEGFR3, epidermal growth factor (EGF), MET, RET, platelet derived growth factor (PDGF)B, PDGFRB and innate immunity related receptors such as toll-like receptors (TLR)2 and TLR9 in ASPS
https://www.sciencedirect.com/science/a ... 2218314306
they do not mention FGFR4 but we have seen that there might be difference between the patients especially based on the age as innate factors change as we age.
So in general, we do not know if it makes sense to seek the enrollment into the FGFR4 clinical trial. Right now she is on the best clinical trial as it shows by far the best results in ASPS by now, just try not to interfere with it. It is good that the antibiotics were avoided. What are the blood work results - any deviations from norm, any problems, what is the neutrophil/lymphocyte ratio (NLR)? I keep the table with the results Ivan get to watch for the changes and problems.